Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Technology Sector · Guggenheim

RYOIX Alternatives & Equivalents

Ticker RYOIX · · Holdings as of Jun 30, 2026

Expense ratio
1.38%$138/yr per $10k
5-yr return
+4.0%annualized
1-yr return
+30.7%as of Dec 2025
Net assets
$136.8Mall share classes
Holdings
74

Bottom line

What is similar to RYOIX?

We compared RYOIX's top holdings against every technology sector fund. The closest match is BBH (VanEck Biotech ETF), with about 64% portfolio overlap. The cheapest similar fund is IBBQ at 0.19% vs 1.38% for RYOIX. Equivalents exist at Invesco, iShares, Fidelity.

RYOIX equivalent at each fund company

Useful if your 401(k) or brokerage only offers one family's funds — for example, the Fidelity or Schwab equivalent of RYOIX.

Best overlap match per family (minimum 50% overlap)
FamilyEquivalentExpense ratio5-yr returnOverlap
Invesco equivalent of RYOIXIBBQ Invesco Nasdaq Biotechnology ETF0.19%—58%
iShares equivalent of RYOIXIBB iShares Biotechnology ETF0.44%+2.5%55%
Fidelity equivalent of RYOIXFBIOX Biotechnology Portfolio0.62%+3.5%53%

Funds most similar to RYOIX

Ranked by top-holdings overlap
FundFamilyExpense ratio5-yr returnOverlap
BBH VanEck Biotech ETFVanEck0.35%+2.7%64% Compare
IBBQ Invesco Nasdaq Biotechnology ETFInvesco0.19%—58% Compare
IBB iShares Biotechnology ETFiShares0.44%+2.5%55% Compare
BIB ProShares Ultra Nasdaq BiotechnologyProShares0.95%−1.0%53% Compare
FBIOX Biotechnology PortfolioFidelity0.62%+3.5%53% Compare
FBTAX Fidelity Advisor Biotechnology FundFidelity0.94%+6.4%47% Compare
FBDIX Franklin Biotechnology Discovery FundFranklin Templeton1.01%+5.0%45% Compare
PBE Invesco Biotechnology & Genome ETFInvesco0.59%+3.4%37% Compare
FBT First Trust NYSE Arca Biotechnology…First Trust0.55%+4.3%30% Compare
SHPAX Health & Biotechnology PortfolioSaratoga Advantage3%+3.1%23% Compare

Overlap = share of the two funds' top-25 holdings (by weight) that they have in common, from SEC Form N-PORT. Funds that hold other funds are matched by benchmark when holdings aren't comparable.